Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission
Apply
Decitabine, Venetoclax, Gilteritinib, Enasidenib, Ivosidenib
Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step